
Jazz Pharmaceuticals plc JAZZ
$ 170.8
0.78%
Quarterly report 2025-Q3
added 11-05-2025
Jazz Pharmaceuticals plc DIO Ratio 2011-2025 | JAZZ
Annual DIO Ratio Jazz Pharmaceuticals plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 224 | 159 | 143 | 118 | 69.4 | 93.3 | 103 | 123 | 102 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 224 | 69.4 | 126 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aclaris Therapeutics
ACRS
|
42.1 | $ 3.04 | 4.83 % | $ 235 M | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 1.17 | 4.46 % | $ 6.38 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Aptevo Therapeutics
APVO
|
112 | $ 0.93 | -8.81 % | $ 257 K | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
132 | $ 26.81 | 1.36 % | $ 1.3 B | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
247 | $ 9.48 | 0.96 % | $ 139 M | ||
|
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
125 | - | - | $ 546 M | ||
|
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B | ||
|
Axon Enterprise
AXON
|
116 | $ 591.15 | 0.02 % | $ 44.8 B | ||
|
Aytu BioScience
AYTU
|
209 | $ 2.53 | -0.39 % | $ 15.9 M | ||
|
AstraZeneca PLC
AZN
|
206 | $ 92.45 | 0.34 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 12.37 | 2.06 % | $ 814 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
239 | $ 10.81 | 2.95 % | $ 699 M | ||
|
Biogen
BIIB
|
394 | $ 176.33 | 0.86 % | $ 25.7 B | ||
|
Abeona Therapeutics
ABEO
|
265 | $ 5.41 | 2.08 % | $ 116 M | ||
|
ADiTx Therapeutics
ADTX
|
220 | $ 1.14 | -9.52 % | $ 15 K |